Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.

Zhang P, Li J, Wang Z, Zhao L, Qiu J, Xu Y, Wu G, Xia Q

Open source

DOI
10.3389/fonc.2023.1077309
Published
2023
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1077309,
  title = {Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.},
  author = {Zhang P and Li J and Wang Z and Zhao L and Qiu J and Xu Y and Wu G and Xia Q},
  year = {2023},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2023.1077309},
  url = {https://doi.org/10.3389/fonc.2023.1077309}
}

RIS

TY  - JOUR
TI  - Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
AU  - Zhang P
AU  - Li J
AU  - Wang Z
AU  - Zhao L
AU  - Qiu J
AU  - Xu Y
AU  - Wu G
AU  - Xia Q
PY  - 2023
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2023.1077309
UR  - https://doi.org/10.3389/fonc.2023.1077309
ER  - 

APA

P, Z., J, L., Z, W., L, Z., J, Q., Y, X., G, W., & Q, X. (2023). Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.. Frontiers in oncology. https://doi.org/10.3389/fonc.2023.1077309

Source records